baber/WOPTO huggingface dataset:
Patent PT-1355725-E (PT)
Inventor: WILLEM DEN BRINK RUDOLF VAN
IPC: B01D53/86
Filed: 2002-01-31
Abstract: A method for the simultaneous removal of nitrogen oxides and laughing gas from a stream containing nitrogen oxides and laughing gas, wherein a first catalyst that contains cobalt and, as support, an inorganic metal oxide, and a second catalyst that contains iron and, as support, an inorganic metal oxide, are used. In particular the method is carried out in such a way that (a) the gas stream containing nitrogen oxides and laughing gas is reacted with a reducing gas, the reducing gas comprising a saturated hydrocarbon, in the presence of the first catalyst and (b) the gaseous product from step (a) is reacted with a reducing gas, the reducing gas comprising a saturated hydrocarbon, in presence of a second catalyst. The catalyst system can be used for the treatment of off-gases from a nitric acid plant.
Patent PT-1397167-E (PT)
Title: Wound closure system and methods
Inventor: LUTHRA AJAY KUMAR
IPC: A61P7/04
Filed: 2002-05-09
Abstract: A wound closure system and methods utilizes a patient's own blood. The system preferably includes a chamber with a needle and a plunger for transferring and storing blood prior to surgery and the use of reversible anticoagulants. The chamber is pre-loaded with a reversible anticoagulant to prevent the blood from clotting during storage. When the surgery is complete, a counteracting agent is mixed with the withdrawn blood to counteract the reversible anticoagulant and allow the blood to clot. The clottable blood is then reintroduced into the patient to close a wound.
Patent PT-1555371-E (PT)
Title: Shock and rattle damper
Inventor: WILDE GERRIT JAN DE
IPC: E05F5/08
Filed: 2004-02-06
Abstract: The buffer (3) comprises a casing (6) for locating in a bore (8) in the fixed or movable wing (1), a sliding stop (4) protruding from the open front side of the casing and capable of being moved in its length direction so that it becomes engaged with the other wing, a spring (7) for urging the stop towards the other wing and a stop mechanism defining the end position of the sliding stop.
Patent PT-1796713-E (PT)
Title: Use of gilz proteinto modulate an antigen-specific immune response
Inventor: EMILIE DOMINIQUE
IPC: A61K39/00
Filed: 2005-09-09
Abstract: A pharmaceutical composition comprising at least dendritic cells modified with a molecule selected from the group consisting of: a GILZ protein or a functional fragment of at least 5 consecutive amino acids of said protein; a small interfering RNA (siRNA) targeting the GILZ transcript or an antisense oligodeoxynucleotide complementary to said transcript; and a recombinant expression vector containing a polynucleotide encoding said GILZ protein, said fragment, said siRNA or said antisense oligodeoxynucleotide complementary to said transcript and a pharmaceutically acceptable carrier. In addition, a method for treatment of autoimmune diseases, inflammatory diseases, allergies, transplant rejection and graft-versus-host disease, cancers or pathogenic microorganism infections by administering an effective amount of said pharmaceutical composition to a subject in need thereof.
Patent PT-1845084-E (PT)
Title: Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomethylcyclopropane
Inventor: NIIMOTO YOSHIHIDE
IPC: A61K31/16
Filed: 2006-01-26
Abstract: The present invention provides a process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2-phthalimidometh ylcyclopropane, which includes reacting (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2-hydroxymethylcy clopropane with an orthoester and a brønsted acid, and reacting the reaction product with a phthalimidating agent; and a process for producing (Z)-1-phenyl-1-(N,N-diethylaminocarbonyl)-2-aminomethylcycl opropane hydrochloride through the above process.
Patent PT-1930404-E (PT)
Title: Method and device for the anaerobic fermentation of organic material
Inventor: SMIS JAN
IPC: C07G99/00
Filed: 2007-11-23
Abstract: Method for the anaerobic fermentation of organic material, whereby the organic material to be fermented is put in a fermentation tank (1) together with an inoculant and moves or is moved from an inlet (6) of the fermentation tank (1) to an outlet (9) thereof, whereby the fermented material is removed from the tank (1) via the outlet (9), characterized in that a fraction of the fermenting material which is situated between the inlet (6) and the outlet (9) is removed from the fermentation tank (1) via a return opening (12) and is used as an inoculant, while the fermenting material between the return opening (12) and the outlet (9) is still after-fermented for a certain while before it is removed from the fermentation tank (1) via the outlet (9).
Patent PT-2258067-E (PT)
Title: Constellation size constrained modulation for ack/nak transmissions
Inventor: MONTOJO JUAN
IPC: H04L1/16
Filed: 2009-03-26
Abstract: Aspects describe maximizing a Euclidean distance for an ACK transmission as a function of the number of bits in a HARQ-ACK and a modulation order. Encoding includes placing escape sequences in the HARQ-ACK, wherein the number of escape sequences is based on the number of bits and the modulation order. Multiple encoded ACK blocks are combined to obtain a vector sequence that is multiplexed with the encoded data and interleaved, such as on a "time-first" manner. Scrambling is performed as a function of the size and the modulation order. For a 1-bit ACK, the scrambling is performed to achieve any two corners in any constellation for transmission for the ACK. For a 2-bit ACK, the scrambling is performed to achieve any four corners in any constellation for transmission for the ACK.
Patent PT-649607-E (PT)
Inventor: O'REILLY ROSEMARY ELIZABETH
IPC: A24D3/04
Filed: 1994-09-26
Abstract: This invention relates to a method which provides in a cigarette filter element a capsule containing a deodoriser. The capsule is resistant to the handling endured before and during smoking, and is ruptured to release or expose the deodoriser after smoking has occurred and upon extinguishing of the smoked cigarette. The deodoriser may comprise neutralising or masking agents, or mixtures of both. <IMAGE>
Patent PT-707884-E (PT)
Inventor: ROBERT RAUTENBACH PROF DR ING
IPC: B01D63/08
Filed: 1995-08-11
Abstract: An assembly filters and separates esp. flowing biological organic media by means of reverse osmosis, micro-, ultra- and nano-filtration within a pressurised housing. The housing has a fluid inlet and outlets for the permeate and retentate. The housing encompasses a number of filter elements forming a membrane cushion around which the flowing media (15) move. The novelty is that a number of membrane cushions (17) are arranged in stacks (18) within the housing (11), and that the cushions are arranged in series or parallel; further that the fluid medium (15) flows around the cushions arranged in series or parallel.
Patent PT-750619-E (PT)
Inventor: OLIVA AMBROGIO
IPC: C07D471/06
Filed: 1995-03-08
Abstract: This invention is directed to heteroannulated indazoles namely to 2,5-disubstituted quinolino-, isoquinolino-, phthalazino-, and quinoxalino- annulated indazole-6(2H)-ones and related mono N-oxides. These compounds have been shown to have antitumor activity.
Patent PT-796240-E (PT)
Inventor: DUBERTRET CATHERINE
IPC: A61K47/48
Filed: 1995-12-04
Abstract: PCT No. PCT/FR95/01595 Sec. 371 Date Jun. 4, 1997 Sec. 102(e) Date Jun. 4, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/17823 PCT Pub. Date Jun. 13, 1996Cationic lipids of general formula (I), wherein m is an integer from 2 to 6 inclusive; n is an integer from 1 to 9 inclusive, preferably 1-5, where, when n is 2-9, a single R grouping other than hydrogen is present in the general formula, and m has variable or identical values within the groupings (a) or -(CH2)m; R is a hydrogen atom or a radical of general formula (II), wherein X or X1, which are the same or different, are an oxygen atom, a methylene grouping -(CH2)q- where q is 0, 1, 2 or 3, or an amino grouping -NH- or NR1-, where R is a C1-4 alkyl grouping; Y and Y1, which are the same or different, are a hydrogen atom or an optionally substituted C1-4 alkyl radical, and p is 0-5; and R6 is a cholesterol derivative or an alkylamino grouping -NR1R2, where R1 and R2 are, independently of each other, a straight or branched, saturated or unsaturated C12-22 aliphatic radical. Pharmaceutical compositions containing said lipids, and their uses for transfecting nucleic acids whether in vitro or in vivo in cells, are also disclosed.
Patent PT-745302-E (PT)
Inventor: TOWNSHEND BRENT
IPC: H04M11/00
Filed: 1995-12-04
Abstract: A new data communication system is described which enables data transmission over existing telephone lines at rates higher than possible with existing methods, including conventional modems. By using a novel asymmetric configuration of the two communication endpoints, the currently-accepted maximum theoretical limits on the data rate are no longer applicable. One endpoint is connected directly to a digital telephone network, whereas the other endpoint uses a conventional telephone connection. This reduces the transmission problem to compensation for a single telephone line interface and a single analog local loop. Means of providing this compensation and the required clock synchronization were also created, enabling a practical implementation of the system. The new system can achieve rates up to 64,000 bits-per-second and has broad utility in several active areas including wide-band audio transmission, video transmission, networking, facsimile transmission, and remote computer access.
Patent PT-814155-E (PT)
Inventor: MORITA TAKASHI
IPC: C12N9/64
Filed: 1996-02-29
Abstract: A novel prothrombin-activating enzyme which will be applied to the diseases wherein thrombin participates. The enzyme is obtained from snake venom and characterized by being calcium-requiring and comprising three polypeptide chains composed of one heavy chain with a molecular weight of about 62,000 or 60,000 and two light chains having molecular weights of, respectively, about 17,000 and about 14,000.
Patent PT-815261-E (PT)
Inventor: FU DONG-JING
IPC: C12Q1/68
Filed: 1996-03-18
Abstract: The invention provides fast and highly accurate mass spectrometer based processes for detecting a particular nucleic acid sequence in a biological sample. Depending on the sequence to be detected, the processes can be used, for example, to diagnose a genetic disease or chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, or for determining identity or heredity.
Patent PT-944592-E (PT)
Inventor: DAEHNE WELF VON
IPC: A61P11/06
Filed: 1997-11-28
Abstract: A compound of formula (I) in which formula Q is a C1-C6 hydrocarbylene diradical; Y is either a single bond, a carbonyl group or a methylene, ethylene, -CH(OH)-, -O-(C 6 H 4)- (ortho, meta, para) or -S-(C 6 H 4)-(ortho, meta, para) diradical; R 1 and R 2, which may be the same or different, stand for hydrogen or a C 1 -C 6 hydrocarbyl radical; or R 1 and R 2 , when taken together with the carbon atom (starred in formula 1) bearing the group Z, can form a C 3 -C 6 carbocyclic ring; and Z is hydrogen or hydroxy; with the proviso that when, at the same time, Q is ethylene Y is methylene, R 1 and R 2 stand for methyl or trifluoromethyl, and Z is hydroxy, or when, at the same time, Q is ethylene, Y stands for carbonyl or -CH(OH)-, R 1 and R 2 are methyl, and Z is hydroxy, then the configuration at C-20 cannot be E. The compounds show anti-inflammatory and immunomodulating effects as well as strong activity in inducing differentiation and inhibiting undesirable proliferation of certain cells.
Patent PT-954341-E (PT)
Title: Intraocular lens containing releasable medication
Inventor: AIACHE JEAN-MARC
IPC: A61L27/54
Filed: 1997-12-15
Abstract: An intraocular implant adapted to come in contact with the aqueous humor comprises a hydrophilic polymer having a predetermined water content for implantation in an eye, an effective quantity of a medicated product for treatment of the eye being dispersed in the mass of the hydrophilic polymer of the implant, the association of the hydrophilic polymer and the dispersed medicated product being adapted to release the product progressively into the aqueous humor.
Patent PT-1076550-E (PT)
Inventor: TRAVSS EDWARD A
IPC: A61K8/21
Filed: 1999-04-27
Abstract: A method is disclosed for enhancing fluoride availability using an acidulated two component dentifrice system in which the first component contains sodium fluoride and a silica abrasive in an alkaline environment and the second component contains an acid, a phosphate ion source, and a silica abrasive.
Patent PT-1207821-E (PT)
Inventor: SCHAR MANUEL
IPC: A61F2/44
Filed: 1999-08-27
Abstract: An intervertebral implant is shaped in the form of a hollow cylinder and has a cover face, a base face, a hollow cylinder wall with an outer lateral area and an inner lateral area, as well as a hollow cylinder central axis. The implant is formed at least 95 percent by volume of a radiolucent material which has a modulus of elasticity of between 1 and 20 GPa. Postsurgical observation is permitted by means of X-rays, and at the same time the implant has a high degree of biocompatibility.
Patent CA-2002806-F (CA)
Inventor: HEDRICK NEVILLE ALLAN
IPC: E21B41/00
Filed: 1989-11-10
Granted: 1990-05-14
Abstract: A rock anchor (10) characterised by a tendon (12) composed of a plurality of strands (14, 15), the tendon (12) having at least one bulbous portion (16), wherein all the strands (14, 15) in the or each bulbous portion (16) are spaced apart from one another substantially around the periphery (17) of each bulbous portion (16) . The tendon (12) is comprised of a plurality of outer strands (14) helically wound around a centre strand (15).  In each bulbous portion (16) the outer strands (14) and the centre strand (15) are disposed adjacent the bulb periphery (17) .
Patent IE-44140-L (IE)
Title: Floor grid
IPC: A01K1/015
Filed: 1977-01-06
Abstract: A floor grid for use in keeping animals, comprises a plurality of juxtaposed wooden bars which are transversely spaced apart to define gaps between them, and a covering on the top of each bar. The covering has downwardly depending longitudinal edge portions that extend downwardly along opposite sides of each bar, and laterally protruding portions that are integral with the downwardly depending longitudinal edge portions and that also extend downwardly along the sides of the bars. The laterally protruding portions are spaced apart along the bars to space the bars apart laterally.
Patent IE-900096-L (IE)
Title: Liquid detergent composition containing enzyme and enzyme¹stabilization system
IPC: C11D10/02
Filed: 1990-01-10
Abstract: Stabilization systems for high pH, aqueous liquid detergent compositions containing detergent enzyme and peroxygen bleaches are disclosed. The detergent compositions contain magnesium salts as an enzyme stabilizing system.
Patent IE-36437-L (IE)
Title: Treatment of lignocellulose material.
IPC: A23K10/32
Filed: 1972-02-22
Abstract: 1366138 Animal feeds UNILEVER Ltd 22 Feb 1972 [24 Feb 1971 14 July 1971] 5275/71 and 33030/71 Heading A2B A mixture comprising a lignocellulose material, for example straw, and a strongly alkaline aqueous solution, having at least 30 wt. % content, is subjected to intense mechanical working at at least 60‹C to give a feed. The thus-treated material may be neutralised by means of an acid substance, for example an inorganic urea salt such as the phosphate, or hydrochloric or acetic acid, preferably with further intense mechanical working. The feed may be extruded or pelletted.
[GB1366138A]
Patent IE-790765-L (IE)
Title: 4-aza-5ó-androstanones and their a- and d- homoanalogues
IPC: C07J33/00
Filed: 1979-08-08
Abstract: 4-Aza-17-substituted-5 alpha -androstan-3-ones and their A- and D- homo analogs of the formula: <CHEM> where Formula (I) may also have the structure of partial Formulas (II) and or (III); wherein, A is (1) - CH2 - CH2 -; (2) - CH = CH -; <CHEM> or <CHEM> B is (1) <CHEM> where R<1> is, (a) hydrogen; (b) methyl or ethyl; (c) ethenyl; (d) ethynyl; (e) NR<2>R<3> where R<2> and R<3> are hydrogen or methyl; (f) cyano; or <CHEM> where X<(-)> is any anion and R<4> is , (a) OR<5 >where R<5> is C1-4 alkyl; or (b) NR<6>R<7>, where R<6> and R<7> are hydrogen or methyl; R min is hydrogen or methyl; R sec is hydrogen or beta -methyl; R''' is B-methyl or hydroxy; Z is (1) oxo ; (2) beta -hydrogen and alpha -hydroxy; or alpha -hydrogen or alpha -hydroxyl and (3) (Y)n Q where n = 0 or 1, Y is a straight or branched hydrocarbon chain of 1 to 12 carbon atoms and Q is (a) <CHEM> , where R<8> is, (i) hydrogen, (ii) hydroxyl, (iii) C1-4 alkyl (iv) NR<9> R<1><0>, where R<9> and R<1><0> are each independently selected from hydrogen, C1-4 straight or branched chain alkyl, C3-6 cycloalkyl, phenyl; or R<9>9 and R<1><0> taken together with the nitrogen to which they are attached represent a 5-6 membered saturated ring comprising up to one other heteratom selected from oxygen and nitrogen. (v) OR<1><1>, where R<1><1> is M, where M is hydrogen or alkali metal, or C1-18 straight or branched chain alkyl; benzyl; or (b) OR<1><2>, where R<1><2> is, (i) C1-20 alkylcarbonyl , (ii) phenyl C1-6 alkylcarbonyl, (iii) C5-10 cycloalkylcarbonyl, (iv) benzoyl, or (v) C1-8 alkoxycarbonyl; (4) <CHEM> where the dashed bond replaced the 17 alpha hydrogen; (5) NH@-R<1><3>, where R<1><3>, is (a) C1-12 alkyl; or (b) NR<9>NR<1><0>; (6) cyano; or (7) tetrazolyl; and pharmaceutically acceptable salts of the above compounds; active as testosterone 5 alpha -reductase inhibitors, and thus useful topically for treatment of acne, seborrhea, female hirsutism and male pattern baldness, and systemically in treatment of benign prostatic hypertrophy, breast carcinoma, and prostate carcinoma.
[EP0004949A1]
Patent IE-45050-L (IE)
Title: Portable manicuring unit
IPC: A45D29/18
Filed: 1977-05-05
Abstract: A portable, battery-operated manicuring machine is disclosed in which the batteries and the final output shaft are aligned substantially coaxially. The motor and actuating switch are positioned within the housing intermediate the battery chamber and the final drive unit with the motor being radially offset from the axis of alignment of the drive unit, batteries and housing and the switch being positioned diametrically opposite the motor. The drive between the motor and the final output shaft includes a gear reduction train comprising a pinion gear on the motor output shaft, a cluster gear having it's larger-diameter gear in meshing relationship with the pinion gear and its smaller gear in meshing relationship with an internally-toothed gear and the output shaft.
[US4103694A]
Patent IE-820958-L (IE)
Title: Delay detonator
IPC: F42B3/16
Filed: 1982-04-23
Abstract: improved uniformity of timing, and particularly reduced sensitivity of timing to minor variations in delay charge size, are achieved in delay detonators by placing a loose load of a flame-sensitive ignition composition between a pressed delay charge and an ignition assembly, e.g., a percussion primer, at the actuation end of the detonator. The loose ignition charge has a free surface and is adapted to be ignited in response to direct contact with flame emitted from the ignition of a charge in the ignition assembly. Preferably, the delay charge is pressed into a plastic carrier which, in a non-electric detonator, has an open end terminating between the walls of the detonator shell and a primer shell that closes the actuation end of the detonator, and the ignition charge is loosely loaded into a metal capsule seated against the delay charge.
Patent FI-821218-L (FI)
Inventor: KUCH HEINZ
IPC: C07D209/36
Filed: 1982-04-06
Abstract: Oxindole derivatives of the general formula I    <IMAGE>  (I)  are described, and also processes for their preparation and drugs containing them. The new compounds exhibit a neuroanabolic action in various animal models.
Patent FI-824376-L (FI)
Inventor: THOMPSON CHARLES
IPC: D03D25/00
Filed: 1982-12-20
Abstract: A papermakers' fabric, having a repeating pattern of floats on its paper support surface is provided with surface floater yarns interspaced between adjacent yarns to improve sheet support characteristics of the fabric. The floater yarns are characterized by lack of interlacing with yarns transverse thereto. The floater yarns are "trapped" beneath the surface floats and are of a diameter generally less than the diameter of the adjacent yarns.
Patent IE-43312-L (IE)
Title: Propanolamine derivatives
IPC: A61K31/215
Filed: 1976-05-20
Abstract: 1493998 Propanolamine derivatives BEECHAM GROUP Ltd 25 May 1976 [3 June 1975] 24005/75 Heading C2C Compounds of the general formula (R 1 =H, C 1-4 alkyl, benzyl; R 2 = H, C 1-4 alkyl or NR 1 R 2 = 5-7 membered saturated hererocyclic group; R 3 =H, C 1-4 alkyl or acyl; R 4 = phenyl, substituted phenyl, naphthyl; R 5,6 = H, C 1-4 alkyl; broken line=single or double bond; X = O, CH 2 ) and their salts are prepared by standard methods, e.g. reaction of the corresponding oxirane and amine, optionally followed by acylation and/or salt formation. The diethers may be prepared by quaternation, alkylation and hydrogenolysis. The preparation of the oxiranes is described. Some of the above compounds are antidepressants and/or anorectics, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
[GB1493998A]
Patent IE-41079-L (IE)
Title: Antibiotics a-28086
IPC: A23K20/195
Filed: 1975-06-05
Abstract: The novel antibiotic A-28086 complex containing the factors A, B and D is produced by culturing Streptomyces aureofaciens NRRL 5758 or Streptomyces aureofaciens NRRL 8092 in a culture medium, which contains assimilable sources for carbohydrate, nitrogen and inorganic salts, in submerged aerobic fermentation conditions until these organisms have produced a significant amount of antibiotic activity in the culture medium. The antibiotic is then separated off from the culture medium. The novel antibiotic can be dissociated into the factors A, B and D. These can be converted into the corresponding physiologically tolerated salts. The novel antibiotic can likewise be converted into C2-C6-acyl esters. The novel antibiotic A-28086 complex, the factors A, B and D, the physiologically tolerated salts thereof and also C2-C6-acyl esters thereof are used to increase the feed intake of ruminants. They can additionally be used for the prevention or treatment of coccidiosis in poultry.
[GB1512568A]